Heron Therapeutics HRTX
NASDAQ HRTX
$0.31 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Receivables - Other (2021 - 2025)

Updated

Heron Therapeutics' Receivables - Other came in at $344,000 for Q4 2025, up 64.6% from $209,000 a year earlier.

Analysis

Heron Therapeutics (HRTX) Receivables - Other (2021 - 2025) Analysis & Trends

Going back to Q4 2021, Heron Therapeutics' Receivables - Other data covers 5 quarters.

  • Receivables - Other carries a four-year compound annual growth rate of 35.2% (FY2021 to FY2025).
  • Going back by year, Receivables - Other was $209,000 in FY2024 (+895.2%), $21,000 in FY2023 (-99.7%), $6.2 million in FY2022 and $103,000 in FY2021.
  • The Q4 2025 figure represents the highest quarterly Receivables - Other since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 344,000.00
Dec 31, 2024 209,000.00
Dec 31, 2023 21,000.00
Dec 31, 2022 6.20 Mn
Dec 31, 2021 103,000.00
API Access

Heron Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=HRTX&period=max&api_key=YOUR_API_KEY